FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3003385728> ?p ?o ?g. }

• W3003385728 abstract "Background Catheter ablation is an effective treatment for atrial fibrillation ( AF ), but high levels of post‐procedure inflammation predict adverse clinical events. Ascorbic acid ( AA ) has shown promise in reducing inflammation but is untested in this population. We sought to test the feasibility, safety, and preliminary effects on inflammatory biomarkers in the CITRIS‐AF (Vitamin C Intravenous Treatment In the Setting of Atrial Fibrillation Ablation) pilot study. Methods and Results Patients scheduled to undergo AF ablation (N=20) were randomized 1:1 to double‐blinded treatment with AA (200 mg/kg divided over 24 hours) or placebo. C‐reactive protein and interleukin‐6 levels were obtained before the first infusion and repeated at 24 hours and 30 days. Pain levels within 24 hours and early recurrence of AF within 90 days were recorded. Median and interquartile range were aged 63 (56–70) years, 13 (65%) men, and 18 (90%) white. Baseline data were similar between the 2 groups except ejection fraction. Baseline C‐reactive protein levels were 2.56 (1.47–5.87) mg/L and similar between groups ( P =0.48). Change in C‐reactive protein from baseline to 24 hours was +10.79 (+6.56–23.19) mg/L in the placebo group and +3.01 (+0.40–5.43) mg/L in the AA group ( P =0.02). Conversely, change in interleukin‐6 was numerically higher in the AA group, though not statistically significant ( P =0.32). One patient in each arm developed pericarditis; no adverse events related to the infusions were seen. There were no significant differences between aggregated post‐procedure pain levels within 24 hours or early recurrence of AF (both P >0.05). Conclusions High‐dose AA is safe and well tolerated at the time of AF ablation and may be associated with a blunted rise in C‐reactive protein, although consistent findings were not seen in interleukin‐6 levels. Further studies are needed to validate these findings and explore the potential benefit in improving clinically relevant outcomes. Clinical Trial Registration URL : http://www.clinicaltrials.gov . Unique identifier: NCT 03148236." @default.
• W3003385728 created "2020-02-07" @default.
• W3003385728 creator A5042864155 @default.
• W3003385728 creator A5049329994 @default.
• W3003385728 creator A5058692516 @default.
• W3003385728 creator A5066843009 @default.
• W3003385728 creator A5073167348 @default.
• W3003385728 creator A5075834050 @default.
• W3003385728 creator A5080876913 @default.
• W3003385728 creator A5087349394 @default.
• W3003385728 creator A5087664362 @default.
• W3003385728 date "2020-02-04" @default.
• W3003385728 modified "2023-09-26" @default.
• W3003385728 title "Vitamin C Intravenous Treatment In the Setting of Atrial Fibrillation Ablation: Results From the Randomized, Double‐Blinded, Placebo‐Controlled CITRIS‐AF Pilot Study" @default.
• W3003385728 cites W1519286283 @default.
• W3003385728 cites W1554807855 @default.
• W3003385728 cites W2006592697 @default.
• W3003385728 cites W2029823871 @default.
• W3003385728 cites W2034187191 @default.
• W3003385728 cites W2110563641 @default.
• W3003385728 cites W2152465977 @default.
• W3003385728 cites W2171998001 @default.
• W3003385728 cites W2612100421 @default.
• W3003385728 cites W2795160781 @default.
• W3003385728 cites W2810864124 @default.
• W3003385728 doi "https://doi.org/10.1161/jaha.119.014213" @default.
• W3003385728 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7033876" @default.
• W3003385728 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32013700" @default.
• W3003385728 hasPublicationYear "2020" @default.
• W3003385728 type Work @default.
• W3003385728 sameAs 3003385728 @default.
• W3003385728 citedByCount "1" @default.
• W3003385728 countsByYear W30033857282021 @default.
• W3003385728 crossrefType "journal-article" @default.
• W3003385728 hasAuthorship W3003385728A5042864155 @default.
• W3003385728 hasAuthorship W3003385728A5049329994 @default.
• W3003385728 hasAuthorship W3003385728A5058692516 @default.
• W3003385728 hasAuthorship W3003385728A5066843009 @default.
• W3003385728 hasAuthorship W3003385728A5073167348 @default.
• W3003385728 hasAuthorship W3003385728A5075834050 @default.
• W3003385728 hasAuthorship W3003385728A5080876913 @default.
• W3003385728 hasAuthorship W3003385728A5087349394 @default.
• W3003385728 hasAuthorship W3003385728A5087664362 @default.
• W3003385728 hasBestOaLocation W30033857281 @default.
• W3003385728 hasConcept C119060515 @default.
• W3003385728 hasConcept C126322002 @default.
• W3003385728 hasConcept C141071460 @default.
• W3003385728 hasConcept C142724271 @default.
• W3003385728 hasConcept C164705383 @default.
• W3003385728 hasConcept C168563851 @default.
• W3003385728 hasConcept C185592680 @default.
• W3003385728 hasConcept C197934379 @default.
• W3003385728 hasConcept C204787440 @default.
• W3003385728 hasConcept C27081682 @default.
• W3003385728 hasConcept C2776131983 @default.
• W3003385728 hasConcept C2776914184 @default.
• W3003385728 hasConcept C2778198053 @default.
• W3003385728 hasConcept C2779161974 @default.
• W3003385728 hasConcept C2781195455 @default.
• W3003385728 hasConcept C2908647359 @default.
• W3003385728 hasConcept C2986274086 @default.
• W3003385728 hasConcept C31903555 @default.
• W3003385728 hasConcept C42219234 @default.
• W3003385728 hasConcept C71924100 @default.
• W3003385728 hasConcept C78085059 @default.
• W3003385728 hasConcept C90924648 @default.
• W3003385728 hasConcept C99454951 @default.
• W3003385728 hasConceptScore W3003385728C119060515 @default.
• W3003385728 hasConceptScore W3003385728C126322002 @default.
• W3003385728 hasConceptScore W3003385728C141071460 @default.
• W3003385728 hasConceptScore W3003385728C142724271 @default.
• W3003385728 hasConceptScore W3003385728C164705383 @default.
• W3003385728 hasConceptScore W3003385728C168563851 @default.
• W3003385728 hasConceptScore W3003385728C185592680 @default.
• W3003385728 hasConceptScore W3003385728C197934379 @default.
• W3003385728 hasConceptScore W3003385728C204787440 @default.
• W3003385728 hasConceptScore W3003385728C27081682 @default.
• W3003385728 hasConceptScore W3003385728C2776131983 @default.
• W3003385728 hasConceptScore W3003385728C2776914184 @default.
• W3003385728 hasConceptScore W3003385728C2778198053 @default.
• W3003385728 hasConceptScore W3003385728C2779161974 @default.
• W3003385728 hasConceptScore W3003385728C2781195455 @default.
• W3003385728 hasConceptScore W3003385728C2908647359 @default.
• W3003385728 hasConceptScore W3003385728C2986274086 @default.
• W3003385728 hasConceptScore W3003385728C31903555 @default.
• W3003385728 hasConceptScore W3003385728C42219234 @default.
• W3003385728 hasConceptScore W3003385728C71924100 @default.
• W3003385728 hasConceptScore W3003385728C78085059 @default.
• W3003385728 hasConceptScore W3003385728C90924648 @default.
• W3003385728 hasConceptScore W3003385728C99454951 @default.
• W3003385728 hasLocation W30033857281 @default.
• W3003385728 hasLocation W30033857282 @default.
• W3003385728 hasLocation W30033857283 @default.
• W3003385728 hasLocation W30033857284 @default.
• W3003385728 hasOpenAccess W3003385728 @default.
• W3003385728 hasPrimaryLocation W30033857281 @default.
• W3003385728 hasRelatedWork W10663157 @default.
• W3003385728 hasRelatedWork W14118903 @default.
• W3003385728 hasRelatedWork W18414786 @default.
• W3003385728 hasRelatedWork W18717468 @default.

• next